|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.26 CHF | -1.12% |
|
+0.37% | +4.25% |
| 05:09pm | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 11:54am | Novartis Seen Largely Shielded From US Tariffs | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 278B | |||||
| 930B | |||||
| 527B | |||||
| 379B | |||||
| 371B | |||||
| 289B |
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition